Breakthrough University of Otago Study Exposes Critical Gaps
The latest research from the University of Otago, Wellington, has ignited urgent discussions across New Zealand's healthcare and academic communities. Published in the prestigious BMJ Neurology Open, the study titled Aotearoa New Zealand’s Neurologist Workforce: A 2024 Analysis of Demand, Supply and Projections paints a stark picture of the nation's neurology landscape. Led by Professor Anna Ranta from the Department of Medicine, this comprehensive analysis reveals that despite modest workforce growth over the past decade, New Zealand lags far behind other high-income countries in neurologist numbers per capita.
Neurologists, medical specialists who diagnose and treat disorders of the nervous system—including the brain, spinal cord, and nerves—are essential for managing conditions ranging from common strokes to complex neurodegenerative diseases. The study's findings underscore a systemic issue that demands immediate attention from policymakers, educators, and healthcare leaders.
Current State of the Neurology Workforce in New Zealand
In 2024, New Zealand counted 83 neurologists across public and private sectors, equating to just 67.3 full-time equivalents (FTE). This translates to one neurologist per 74,000 people—a figure that pales in comparison to Australia's one per 41,000 and the best-practice benchmark of one per 28,000 suggested by recent Australian models. Including 8.3 FTE paediatric neurologists, the workforce remains stretched thin, particularly for adult care.
This scarcity means routine access to specialist care is limited. Health New Zealand (Te Whatu Ora) data shows a troubling 1:1 ratio of first assessments to follow-ups, whereas international standards recommend approximately six follow-ups per initial visit. Consequently, only about one in five patients with chronic neurological conditions receives regular neurologist oversight, often leading to suboptimal management and higher long-term costs.
Drivers Behind the Surging Demand for Neurology Services
Several interconnected factors are fueling the neurologist shortage in New Zealand. An aging population is a primary culprit, with neurological disorders projected to become the leading cause of disability and the second-leading cause of death globally by 2030. Conditions like stroke, Alzheimer's disease, multiple sclerosis (MS), and rarer neurogenetic disorders such as spinal muscular atrophy are rising sharply.
Advances in treatments exacerbate the issue. For instance, reperfusion therapies for acute stroke—clot-busting drugs and mechanical thrombectomy—have revolutionized outcomes but require specialized neurologist input, including telemedicine oversight and patient transfers to stroke units. Similarly, disease-modifying therapies for MS have grown more complex, demanding ongoing monitoring. Emerging Alzheimer's treatments on the horizon will further strain resources unless the workforce expands.
- Increasing prevalence of MS, with New Zealand seeing a one-third rise from 2006 to 2022.
- Stroke incidence climbing due to better survival rates and lifestyle factors.
- Rare diseases gaining visibility through genetic testing and novel therapies.
🧠 Limited Training Capacity at New Zealand's Medical Schools
Addressing the shortage starts with education. New Zealand's neurology specialist training, overseen by the Royal Australasian College of Physicians (RACP), spans three years of advanced training after basic medical qualification. However, the country trains only four to five new neurologists annually—insufficient to close the gap.
Medical degrees are offered at two primary institutions: the University of Auckland's Faculty of Medical and Health Sciences and the University of Otago's medical schools in Dunedin, Christchurch, and Wellington. These programs produce graduates who then enter vocational training, but neurology spots are capped. The University of Otago's Neuroscience Programme, for example, provides foundational knowledge in nervous system structure, function, development, and disease, preparing students for specialized paths.
Expanding undergraduate neuroscience offerings and postgraduate neurology fellowships could pipeline more specialists.
Photo by Athithan Vignakaran on Unsplash
Projections: A Widening Gap Without Intervention
The Otago study models workforce trends from 2024 to 2036, projecting a gradual deterioration if current patterns persist. Supply may inch up slightly through retention and modest recruitment, but demand—driven by demographic shifts and therapeutic advances—will outpace it. By 2036, the shortfall could deepen, risking poorer patient outcomes and increased pressure on general practitioners (GPs).
To illustrate:
| Year | Neurologists (Headcount) | FTE Supply | Recommended FTE | Shortfall |
|---|---|---|---|---|
| 2024 | 83 | 67.3 | ~100+ | ~33 |
| 2030 (proj.) | ~90 | ~75 | ~120 | ~45 |
| 2036 (proj.) | ~95 | ~80 | ~140 | ~60 |
Note: Projections based on study trends; exact figures vary by recruitment success.
For aspiring neurologists, opportunities abound in New Zealand university jobs and clinical roles. Check higher education jobs for academic positions blending teaching and research.
Voices from the Frontlines: Expert Insights
Professor Anna Ranta emphasizes, "While the workforce has increased over the past 10 years, the number of neurologists per head of population in New Zealand ranks well below other high-income countries, and demand for services continues to significantly exceed supply." She highlights the equity issue: "Lack of resourcing means not everyone who would benefit from seeing a neurologist has the opportunity to do so."
Dr. David Gow, Te Whatu Ora's regional chief medical officer, acknowledges the research's value: "We know we need to grow our healthcare workforce... We value research papers like this one as they can be considered alongside our own workforce planning." These perspectives call for collaborative action between universities, government, and health authorities.
Explore career paths in medicine via higher education career advice resources tailored for health professionals.
Patient Impacts and Broader Health System Strain
The human cost is profound. Patients face long wait times—sometimes months for initial consultations—and inadequate follow-up, leading to disease progression. A Palmerston North woman, for example, experienced a seizure managed remotely by a GP consulting a distant specialist due to no on-site neurologist. Chronic conditions like epilepsy or Parkinson's worsen without regular monitoring, increasing emergency admissions and GP burdens.
Economically, untreated neurological issues balloon costs: strokes alone cost New Zealand $1.2 billion annually. Proactive neurology care via new treatments yields long-term savings, yet underinvestment perpetuates the cycle. Read the full Otago study summary for deeper data.
Solutions: Expanding Training and Recruitment Efforts
Stakeholders propose multifaceted strategies:
- Increase training slots: Universities like Otago and Auckland could advocate for more RACP-funded positions, potentially doubling output to 8-10 annually.
- International recruitment: Fast-track visas for overseas neurologists, paired with cultural integration programs.
- Telemedicine expansion: Leverage tech to multiply specialist reach, as piloted in stroke care.
- Interdisciplinary models: Train physician associates and nurses in neurology support roles.
- Research investment: Fund neuroscience at unis to attract talent and innovate delivery.
These steps align with Health NZ's workforce plans. For educators, university jobs in medical faculties offer chances to shape future neurologists.
Further reading: RNZ coverage on demand struggles.
The Pivotal Role of New Zealand Universities in Neurology Research
Universities are at the forefront. Otago's neuroscience program delves into brain health and disease, while Auckland excels in stroke and neurodegeneration research. The Centre for Brain Research at Auckland pioneers stem cell therapies, and Otago's Wellington campus drives workforce studies like this one.
These institutions not only train doctors but conduct vital research informing policy. Recent grants, such as $2.6 million for neuro projects, bolster capacity. To combat the shortage, unis must scale postgraduate programs and PhDs in clinical neurology.
Future Outlook and Call to Action
Without bold reforms, New Zealand risks a neurological health crisis. Yet, with university-led innovation, targeted funding, and career incentives, the tide can turn. Aspiring professionals: consider neurology—demand exceeds supply, offering fulfilling roles and job security.
Visit Rate My Professor for insights on med school faculty, browse higher ed jobs and university jobs in NZ, and access higher ed career advice for neurology paths. Post a vacancy at /recruitment to attract top talent. Share your thoughts in the comments below.
